Common-variant associations with fragile X syndrome

James J. Crowley, Jin Szatkiewicz, Anna K. Kähler, Paola Giusti-Rodriguez, Na Eshia Ancalade, Jessica K. Booker, Jennifer L. Carr, Greg E. Crawford, Molly Losh, Craig A. Stockmeier, Annette K. Taylor, Joseph Piven, Patrick F. Sullivan*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Fragile X syndrome is rare but a prominent cause of intellectual disability. It is usually caused by a de novo mutation that occurs on multiple haplotypes and thus would not be expected to be detectible using genome-wide association (GWA). We conducted GWA in 89 male FXS cases and 266 male controls, and detected multiple genome-wide significant signals near FMR1 (odds ratio = 8.10, P = 2.5 × 10 −10 ). These findings withstood robust attempts at falsification. Fine-mapping yielded a minimum P = 1.13 × 10 −14 , but did not narrow the interval. Comprehensive functional genomic integration did not provide a mechanistic hypothesis. Controls carrying a risk haplotype had significantly longer FMR1 CGG repeats than controls with the protective haplotype (P = 4.75 × 10 −5 ), which may predispose toward increases in CGG number to the premutation range over many generations. This is a salutary reminder of the complexity of even “simple” monogenetic disorders.

Original languageEnglish (US)
Pages (from-to)338-344
Number of pages7
JournalMolecular Psychiatry
Volume24
Issue number3
DOIs
StatePublished - Mar 1 2019

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Common-variant associations with fragile X syndrome'. Together they form a unique fingerprint.

  • Cite this

    Crowley, J. J., Szatkiewicz, J., Kähler, A. K., Giusti-Rodriguez, P., Ancalade, N. E., Booker, J. K., Carr, J. L., Crawford, G. E., Losh, M., Stockmeier, C. A., Taylor, A. K., Piven, J., & Sullivan, P. F. (2019). Common-variant associations with fragile X syndrome. Molecular Psychiatry, 24(3), 338-344. https://doi.org/10.1038/s41380-018-0290-3